Shaker R. Dakhil
Cancer Center of Kansas(US)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Lung Cancer Research Studies, Estrogen and related hormone effects
Most-Cited Works
- → Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer(2005)5,340 cited
- → Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27(2008)1,789 cited
- → Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma(2006)1,358 cited
- → Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial(2014)1,290 cited
- → Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study(2020)865 cited
- → Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial(2000)734 cited